PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 13, 2004Neurology185 citations

Antiplatelet drug discontinuation is a risk factor for ischemic stroke

View Full Paper
ISIgor SibonJOJean‐Marc Orgogozo

Structured PICO

Does antiplatelet drug discontinuation affect the timing and risk of ischemic stroke?

P
Population
Patients with stroke
I
Intervention
Recent discontinuation of antiplatelet drugs (APD)
O
Outcome
Frequency of stroke occurring after APD discontinuation, cause of discontinuation, and delay between APD disruption and strokehard clinical

Ischemic strokes related to antiplatelet drug discontinuation exhibit a highly specific temporal pattern, occurring 6 to 10 days after disruption.

Abstract

Antiplatelet drugs (APD) are widely used in the prevention of ischemic cardio- and cerebrovascular diseases. The authors studied the frequency of stroke occurring after APD discontinuation, the cause of discontinuation, and the delay between APD disruption and stroke. Only 4.49% of strokes were related to a recent APD discontinuation, but all cases occurred between 6 and 10 days after drug discontinuation (p < 0.0001). This temporal pattern has biologic plausibility because the inhibited platelets circulate in the blood for about 10 days.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Sibon et al. (2004) studied this question.

synapsesocial.com/papers/6a7770e54fe2e6ffd8ecac10https://doi.org/10.1212/01.wnl.0000118288.04483.02
Ask AI
Helpful
Bookmark
Share
View Full Paper